Investment firm Altus Capital Partners said today it acquired spinal implant maker ChoiceSpine for an undisclosed amount.
Knoxville, Tenn.-based ChoiceSpine develops spinal products including minimally invasive cervical, thoracolumbar, interbody lateral and biologics kits and implants, the groups said.
“We recognize the need in the medical technology space for proven spinal products that can enhance the quality of life for spinal patients. ChoiceSpine, a global medical device corporation specializing in innovative solutions for both spinal fusion hardware and biologics, demonstrates a track record of proven innovation, strong sales growth, increased distribution and the necessity of their products in the marketplace,” Altus co-founder & senior partner Gregory Greenberg said in prepared remarks.
“We look forward to working with Altus in further developing our offerings as well as expanding into new product verticals to continue to grow the company and provide patient solutions for the treatment of spinal disorders,” ChoiceSpine co-founder Marty Altshuler said in a press release.
Last November, Altus Capital Partners said it inked a deal to acquire MGC Diagnostics Corp in a $50.3 million deal.
